Introduction
Influenza virus contains hemagglutinin (HA) and neuraminidase (NA), which were coded as H and N strands, respectively. These H and N strands represent different strains of the virus. 1e3 Generally, immune response loci of HA and NA were used for designing vaccines. The standard World Health Organization procedure for vaccine development 4e6 has provided a guideline for influenza viruses, but no systematic operational model. 4 We recently designed a systemic analysis method to evaluate annual perspective sequence changes of influenza virus strains, and found a better way to design and accelerate the development of vaccines that can be used to combat several viral strains at the same time. This new procedure of vaccine development would reduce at least 3e6 weeks from the standard processing procedure of the World Health Organization. 4 Our design can help scientists shorten the time of blind tests and be a better method for producing vaccines against unknown strains of influenza virus based on previously known flu vaccines.
Our methods could rapidly identify similarity among strains and localize the closest strains. When a new strain of virus is confirmed for disease manifestation, we can instantaneously find the closest pre-made vaccine by whole sequence matching with NeedlemaneWunsch (NeW) dynamic programming to identify the common and reserved antigenic areas. In fact, at the International Engineering Invention and Innovation Exhibition (Malaysia) in March 2013, using the same combinatorial methods, we had predicted that H7N9 could be derived from H7N7; these sequences of the isolated virus were later reported by Lam et al. 7 In this study, we use the same method to analyze sequences of influenza viruses that are most devastating to humans, and plan to develop bioinformatic methods to consolidate the predicting consistency and reliability of our model. By such biological methods, we might be able to quantitatively produce vaccines without compromising their effectiveness against lethal viruses.
Materials and methods

Analysis programs
In this study, we applied the unweighted pair group method with arithmetic mean (UPGMA), 1,8e10 maximum likelihood estimate (MLE), 11 and NeW dynamic programming 12 to evaluate evolutional changes and relationship between viruses in polymerase basic 2 (PB2) and NA, respectively. Two evolution analysis software, dnaml of PHYLIP 3.69 13 and ClustalX2, 10 were used to show the phylogenetic pedigrees among viruses based on the results of MLE and UPGMA, respectively.
Sequences of influenza viruses
The genetic sequences of H1N1 (GenBank: GQ132185. 
Results
To analyze the relationships among various influenza viruses, we collected genetic sequences of H1N1, H1N2, H2N2, H3N2, H3N8, H5N1, H5N2, H5N3, H7N1, H7N2, H7N3, H7N7, and H10N7 from the databases of National Center for Biotechnology Information. Moreover, an influenza virus contains eight nucleic acid fragments that encode 11 proteins, namely PB2, PB2-F1, PB1, PA, HA, NP, NA, M1, M2, NS1, and NS2. 9, 14 The sequence of PB2 reveals the evolutionary origin of a virus and has often been used in phylogenetic analysis. 2, 3, 7, 14 Therefore, the MLE method was used to determine phylogenetic pedigrees of PB2 sequences among viruses. Results showed that H5N3 had the most evolutionary relationship with H7N3, and there was also high similarity between H7N7, H7N9, and H7N2 (Fig. 1A) .
The NA gene of an influenza virus encodes a surface protein that is essential for releasing progeny virions from the infected cell surface and prevent self-aggregation. 15 Thus, the NA has been targeted to design antiviral drugs. In fact, the NA inhibitor is one of the two major classes of antivirals licensed and effectively limits the severity of viral infections. 15 Therefore, we further investigated the NA section of the 14 viruses by UPGMA. In Figs. 1B and 1C , we found that PB2 analysis could be extrapolated to those for NA.
Annual production of influenza virus vaccines was based on historical records used to predict the future prevalence of the disease. 4 However, the error in prediction of influenza virus mutant is inevitable. For example, the lack of a framework for modeling nucleotide insertions/deletions together with nucleotide substitutions would also lead to an error in phylogenetic analysis. To avoid such conditions, multiple alignments of NA were constructed based on the complete nucleotide sequences, using the NeW dynamic programming and then UPGMA for precise calculation and cross-examination (Figs. 1D and 1E) .
To reduce an arithmetic error in the calculation of phylogenetic diversity, we also applied NeW dynamic programming and MLE to evaluate the relationships between 14 viruses in NA sequences ( Figs. 2A and 2B) . The result showed that there was no difference between UPGMA and MLE calculations (Figs. 1D and 2A, and Figs. 1E and 2B,  respectively) .
To find the basic difference between those 14 influenza viruses for the determination of immune loci, we further conducted a continuous analysis of NA sequences by NeW dynamic programming and MLE. We used H7N9 and H5N3 sequences. The total length of H7N9 sequence was 1426 base pairs and that of H5N3 was 1422 base pairs. After calculation, H7N9 was found to have 623 loci of immune response, and 43.32% of blind tests could be reduced. The number of loci of immune response of H5N3 was 191, and reduction in blind tests was 13.55% (Figs. 2C and 2D ).
Discussion
Previously available biomedical information is used for vaccine development; however, in this case, the major problems would be to predict the correct future viral strains that can cause widespread infection and the possible viral mutations that may influence the presentation of effective epitopes to provoke protective immune responses. 16 Projection of the best epitopes is particularly important for influenza viruses, which from time to time become lethal to human beings. Moreover, because of the distinctive features of RNA viruses, persistent gene mutations as well as possible genome recombination and reassortments are inevitable, which by contrast, could generate more deadly strains to cross species barrier, leading to more widespread manifestation.
In this study, we have developed a novel method by combining UPGMA, 1, 8, 9 MLE, and NeW dynamic programming 12 to define the annually detected mutational changes. We used these annual results to determine mutational ranges and the most probable mutation sites in the gene, which could then be used to project by using computer analysis the coming unknown virus which would be the major target for production of the vaccine. 12 In this way, there are many uncertainty products of vaccines which could be eliminated. The derivation of statistical outcomes is shown in Figs. 1De2D . We could not only identify the relationship as well as subtle differences between known viruses, but also pinpoint the most plausible immune loci for biochemical experiments to raise effective antibodies (Figs. 2C and 2D ). In addition, our results could be further extrapolated to the drug design; for instance, the current design of antiviral drugs was focused primarily on NA, such as oseltamivir and zanamivir, both of which are NA inhibitors. 6 However, our results have shown that HAs can be the next potential target, similar to NAs. Moreover, our previous study had been awarded by the 2013 International Biochemical Technology Invention. The patent rights of this new methods for vaccine development are under application via Intellectual Property Rights (IPR) Center of National Chung Hsing University, Taichung, Taiwan (patent numbers: 102134134 and 103111788) 9 and the USA (patent number: 14/482,506). This study could effectively improve the current reversed genetics procedure of vaccine development (Figs. 2C and 2D) . As the best epitopes to provoke appropriate immunity could be identified faster, 3e6 weeks of developing time could be saved. The cost of vaccine development can also be reduced markedly. It also helps medical policy making and provides more protections for peoples.
